Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 4, 2000, Pages 570-572

  Regan, J ^a,b   Chambers, F ^a,b   Gorman, W ^a,b   MacSullivan, R ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NATIONAL MATERNITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; FEMALE; GESTATIONAL AGE; HUMAN; PAIN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; ANALGESICS, OPIOID; FEMALE; FENTANYL; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0034069447     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13282.x     Document Type: Article

References (17)

1. Zelson C, Lee SJ, Casalino M. Comparative effects of maternal intake of heroin and methadone N Engl J Med 1973; 289: 1216–1220.
2. Portenoy RK, Foley KM. Chronic of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25: 171–186.
3. Zenz M, Strumpf M, Tryba M. Long term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992; 7: 69–77.
4. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983; 8: 422–446.
5. Knepp VM, Hadgraft J, Guy RH. Transdermal drug delivery: problems and possibilities. Crit Rev Ther Drug Carrier Syst 1987; 4: 13–37.
6. Morgan DJ. Drug disposition in mother and foetus. Clin Exp Pharmacol Physiol 1997; 24: 869–873.
7. Vella LM, Knott C, Reynolds F. Transfer of fentanyl across the rabbit placenta. Effect of umbilical flow and concurrent drug administration. Br J Anaesth 1986; 58: 49–54.
8. Fernando R, Bonello E, Gill P, Urquhart J, Reynolds F, Morgan B. Spinal epidural analgesia for labour. Anaesthesia 1997; 53: 517–524.
9. Finnegan LP. Effects of maternal opiate abuse on the newborn. Fed Proc 1985; 44: 2314–2317.
10. Hodding GC, Jann M, Ackerman IP. Drug withdrawal syndromes: a literature review. West J Med 1980; 133: 383–391.
11. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecot 1993; 81: 936–940.
12. Katz R, Kelly HW, Hsi A. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med 1993; 21: 995–1000.
13. Gauntlett IS, Fisher DM, Hertzka RE, Kuhls E, Spellman M, Rudolph C. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988; 69: 683–687.
14. Koehntop DE, Rodman JH, Brundage D, Hegland M, Buckley J. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986; 65: 227–233.
15. Finnegan LP. Neonatal abstinence syndrome. In: Nelson NM, editor Current therapy in neonatal/perinatal medicine-2. St Louis: CV Mosby, 1989: 314–320.
16. Finnegan LP, Connaughton JR Jr, Kron RE et al. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2: 141–158.
17. Varvel JR, Shafer SL, Hwang S, Coen P, Stanski DR. Bioavailability and absorption of transdermal fentanyl. Anesthesiology 1989; 70: 928–934.